Intestinal microbiota and melatonin in the treatment of secondary injury and complications after spinal cord injury

Yiwen Zhang,Rui Lang,Shunyu Guo,Xiaoqin Luo,Huiting Li,Cencen Liu,Wei Dong,Changshun Bao,Yang Yu
DOI: https://doi.org/10.3389/fnins.2022.981772
IF: 4.3
2022-11-09
Frontiers in Neuroscience
Abstract:Spinal cord injury (SCI) is a central nervous system (CNS) disease that can cause sensory and motor impairment below the level of injury. Currently, the treatment scheme for SCI mainly focuses on secondary injury and complications. Recent studies have shown that SCI leads to an imbalance of intestinal microbiota and the imbalance is also associated with complications after SCI, possibly through the microbial-brain-gut axis. Melatonin is secreted in many parts of the body including pineal gland and gut, effectively protecting the spinal cord from secondary damage. The secretion of melatonin is affected by circadian rhythms, known as the dark light cycle, and SCI would also cause dysregulation of melatonin secretion. In addition, melatonin is closely related to the intestinal microbiota, which protects the barrier function of the gut through its antioxidant and anti-inflammatory effects, and increases the abundance of intestinal microbiota by influencing the metabolism of the intestinal microbiota. Furthermore, the intestinal microbiota can influence melatonin formation by regulating tryptophan and serotonin metabolism. This paper summarizes and reviews the knowledge on the relationship among intestinal microbiota, melatonin, and SCI in recent years, to provide new theories and ideas for clinical research related to SCI treatment.
neurosciences
What problem does this paper attempt to address?